CPT code 93565 denotes a diagnostic invasive cardiac catheterization where a catheter is placed into the left ventricle or left atrium and contrast dye is injected to evaluate heart structure and function in patients with congenital heart disease. This code captures the physician’s supervision of image acquisition, interpretation of imaging, and formal reporting of findings. Nationally, procedures for congenital heart disease are high-resource, specialized services performed in catheterization laboratories and affect referral patterns, hospital resource allocation, and payer coverage policies.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a clinical and billing overview of the procedure, common modifier usage, typical sites of service, and the clinical context in which the code is used. The publication outlines benchmarks and utilization patterns where available, summarizes relevant coding considerations for documentation and reporting, and highlights implications for payer coverage and prior authorization practices.

The content is written for clinicians, coding professionals, and policy analysts seeking concise guidance on the clinical intent and billing context of 93565, along with what to expect from payer interactions and coding workflows. Data not available in the input is identified where applicable.